Luoxis launches to market oxidation reduction Dx tool

02/12/2013 | RTT News

Luoxis Diagnostics, an Ampio Pharmaceuticals unit, has launched operations to market the Oxidation Reduction Potential diagnostics platform. The technology is designed for use in developing disposable testing strips and a point-of-care reader for various conditions.

View Full Article in:

RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL